Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mary Branch"'
Autor:
Mary Branch
Publikováno v:
American Heart Journal Plus, Vol 36, Iss , Pp 100333- (2023)
Externí odkaz:
https://doaj.org/article/d233b0dbcf894a5bb667f127f32f7f5c
Autor:
Sherry-Ann Brown, Eric H. Yang, Mary Branch, Craig Beavers, Anne Blaes, Michael G. Fradley, Richard K. Cheng
Publikováno v:
Heart failure clinics, vol 18, iss 3
Heart Fail Clin
Heart Fail Clin
Cardiovascular disease is a leading cause of death in cancer survivors, after recurrence of the primary tumor or occurrence of a secondary malignancy. Consequently, the interdisciplinary field of cardio-oncology has grown rapidly in recent years to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68c0dfaafe4db17ea8bfd5ad64df2f7f
https://doi.org/10.1016/j.hfc.2022.02.014
https://doi.org/10.1016/j.hfc.2022.02.014
Autor:
Kerryn W. Reding, Richard K. Cheng, Alexi Vasbinder, Roberta M. Ray, Ana Barac, Charles B. Eaton, Nazmus Saquib, Aladdin H. Shadyab, Michael S. Simon, Dale Langford, Mary Branch, Bette Caan, Garnet Anderson
Publikováno v:
JACC. CardioOncology. 4(1)
Breast cancer (BC) survivors experience an increased burden of long-term comorbidities, including heart failure (HF). However, there is limited understanding of the risk for the development of HF subtypes, such as HF with preserved ejection fraction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036c4f41b98f93639341630e8ba42694
https://pubmed.ncbi.nlm.nih.gov/35492810
https://pubmed.ncbi.nlm.nih.gov/35492810
Autor:
Daniela Cardinale, Mary Branch, Jordana B. Cohen, Miguel Cainzos Achirica, Siddhartha Jaiswal, Fabiani Iacopo, Sherry-Ann Brown, Melissa E. Middeldorp, Prashanthan Sanders
Publikováno v:
Current Treatment Options in Cardiovascular Medicine. 23
To review the most common forms of cardiovascular toxicities from anti-cancer drugs, with a focus on their prevention via cardioprotective pharmacologic or lifestyle therapy, risk factors management, screening, monitoring, and surveillance methods. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d91c4d4181e73e56bfc166398ed0eb18
https://doi.org/10.1007/s11936-020-00883-1
https://doi.org/10.1007/s11936-020-00883-1
Autor:
Dale J. Langford, Michael S. Simon, Garnet L. Anderson, Abu Taiyab Nazmus Saquib, Kerryn W. Reding, Mary Branch, Bette J. Caan, Alexi Vasbinder, Richard Cheng, Ana Barac, Aladdin H. Shadyab, Roberta M. Ray
Publikováno v:
Circulation. 142
Introduction: Breast cancer (BC) survivors (BCS) are at increased risk for incident heart failure (HF). In this population, the risk for HF with preserved ejection fraction (HFpEF) has been understudied compared to HF with reduced EF (HFrEF). The pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f9007496b78f74839f2aa41ecd070af
https://doi.org/10.1161/circ.142.suppl_3.13885
https://doi.org/10.1161/circ.142.suppl_3.13885
Autor:
Tochi M Okwuosa, Celina I. Valencia, Chris L. Schaich, Elsayed Z. Soliman, Aladdin H. Shadyab, Daniel P. Beavers, Kerryn W. Reding, Ana Barac, Gretchen L. Wells, Mary Branch, Mara Z. Vitolins
Publikováno v:
Circulation. 142
Background: Autonomic dysfunction (AD) as measured by heart rate variability (HRV) is associated with increased risk of cardiovascular disease (CVD) and breast cancer. No study has utilized a large prospective multi-center cohort of diverse women to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5be9a21b18ee14c3c8a08f27669f268f
https://doi.org/10.1161/circ.142.suppl_3.13500
https://doi.org/10.1161/circ.142.suppl_3.13500
Publikováno v:
Current Cardiovascular Risk Reports. 14
As cancer screening and treatment continue to improve, the number of cancer survivors is growing rapidly. Cardiovascular disease is the leading cause of death in cancer survivors. In this review, we explore racial and ethnic disparities in cardiovasc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::080ca71e7b64646bd5dc2491dd13aa97
https://doi.org/10.1007/s12170-020-00650-8
https://doi.org/10.1007/s12170-020-00650-8
Publikováno v:
J Cardiovasc Transl Res
Animal models of chemotherapy-induced cardiotoxicity have been instrumental in understanding the underlying mechanisms of the disease. The use of cardiac magnetic resonance (CMR) imaging and nuclear magnetic resonance (NMR) imaging in preclinical mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6225d01e655c573a36396d40df085240
https://europepmc.org/articles/PMC7869107/
https://europepmc.org/articles/PMC7869107/
Publikováno v:
Current Cardiovascular Risk Reports. 16:11-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e42020c52cbdfcd7dc0b48f10a7ccbf4
https://doi.org/10.1007/s12170-022-00688-w
https://doi.org/10.1007/s12170-022-00688-w
Publikováno v:
Journal of diabetes and its complications. 33(7)
Cardiovascular disease (CVD) and chronic kidney disease (CKD) are complications of type 2 diabetes mellitus (DM). Current cholesterol guidelines recommend the same prevention strategy for patients with DM alone as patients with DM + CKD. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4baccd0088ff446c9d3f984cb93fe4c4
https://pubmed.ncbi.nlm.nih.gov/31088728
https://pubmed.ncbi.nlm.nih.gov/31088728